Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
Enovis (NYSE: ENOV), a medical technology growth company, has announced it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results on Wednesday, November 6th, 2024 at 8:30 a.m. Eastern Time. The company will issue an earnings press release earlier that morning. A presentation related to the call will be available on ir.enovis.com.
Investors can access the live webcast via a link on the Enovis website. Those planning to participate on the call should dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A replay of the call will be available on the Enovis website later that day.
Enovis (NYSE: ENOV), un'azienda dedicata alla crescita nel settore della tecnologia medica, ha annunciato che ospiterà una conferenza telefonica per gli investitori e una diretta streaming per discutere i propri risultati finanziari del terzo trimestre 2024 mercoledì 6 novembre 2024 alle 8:30 a.m. Eastern Time. L'azienda pubblicherà un comunicato stampa sugli utili nel corso della mattinata. Una presentazione relativa alla chiamata sarà disponibile su ir.enovis.com.
Gli investitori possono accedere alla diretta streaming tramite un link presente sul sito web di Enovis. Coloro che intendono partecipare alla chiamata devono comporre (833) 685-0901 (per i chiamanti negli Stati Uniti) e (412) 317-5715 (per i chiamanti internazionali) e chiedere di unirsi alla chiamata di Enovis. Una registrazione della chiamata sarà disponibile sul sito web di Enovis in seguito nel corso della giornata.
Enovis (NYSE: ENOV), una empresa de tecnología médica en crecimiento, ha anunciado que llevará a cabo una conferencia telefónica para inversores y una transmisión en vivo para discutir sus resultados financieros del tercer trimestre de 2024 el miércoles 6 de noviembre de 2024 a las 8:30 a.m. hora del Este. La compañía emitirá un comunicado de ganancias más temprano esa mañana. Una presentación relacionada con la llamada estará disponible en ir.enovis.com.
Los inversores pueden acceder a la transmisión en vivo a través de un enlace en el sitio web de Enovis. Aquellos que planeen participar en la llamada deben marcar (833) 685-0901 (llamantes de EE. UU.) y (412) 317-5715 (llamantes internacionales) y solicitar unirse a la llamada de Enovis. Una repetición de la llamada estará disponible en el sitio web de Enovis más tarde ese día.
Enovis (NYSE: ENOV)는 의료 기술 성장 회사로, 2024년 3분기 재무 결과를 논의하기 위해 투자자 컨퍼런스 콜 및 라이브 웹캐스트를 개최한다고 발표했습니다. 이는 2024년 11월 6일 수요일 오전 8:30 동부 표준시에 진행됩니다. 회사는 그날 아침 일찍 수익 보도 자료를 발표할 예정입니다. 전화 회의와 관련된 프레젠테이션은 ir.enovis.com에서 제공될 것입니다.
투자자는 Enovis 웹사이트에서 제공되는 링크를 통해 라이브 웹캐스트에 접속할 수 있습니다. 전화 회의에 참여할 계획인 사람은 (833) 685-0901 (미국 전화기)와 (412) 317-5715 (국제 전화기)로 전화하여 Enovis 회의에 참여하겠다고 요청해야 합니다. 전화 회의의 재생은 그 날 늦게 Enovis 웹사이트에서 제공될 것입니다.
Enovis (NYSE: ENOV), une société de croissance dans le domaine des technologies médicales, a annoncé qu'elle tiendra une conférence téléphonique pour les investisseurs ainsi qu'un webinaire en direct pour discuter de ses résultats financiers du troisième trimestre 2024 le mercredi 6 novembre 2024 à 8h30, heure de l'Est. L'entreprise publiera un communiqué de presse sur ses résultats plus tôt dans la matinée. Une présentation liée à la conférence sera disponible sur ir.enovis.com.
Les investisseurs peuvent accéder au webinaire en direct via un lien sur le site web d'Enovis. Ceux qui prévoient de participer à la conférence doivent composer le (833) 685-0901 (appelants des États-Unis) et le (412) 317-5715 (appelants internationaux) et demander à rejoindre la conférence Enovis. Un enregistrement de la conférence sera disponible sur le site d'Enovis plus tard dans la journée.
Enovis (NYSE: ENOV), ein wachsendes Unternehmen im Bereich der Medizintechnik, hat angekündigt, dass es eine Telefonkonferenz für Investoren und ein Live-Webcast veranstalten wird, um die Finanzergebnisse des dritten Quartals 2024 zu besprechen, und zwar am Mittwoch, den 6. November 2024 um 8:30 Uhr Eastern Time. Das Unternehmen wird an diesem Morgen früher eine Pressemitteilung zu den Ergebnissen veröffentlichen. Eine Präsentation, die sich auf die telefonische Sitzung bezieht, wird auf ir.enovis.com verfügbar sein.
Investoren können über einen Link auf der Enovis-Website auf den Live-Webcast zugreifen. Diejenigen, die an der Konferenz teilnehmen möchten, sollten (833) 685-0901 (US-Anrufer) und (412) 317-5715 (internationale Anrufer) wählen und um Teilnahme an der Enovis-Konferenz bitten. Eine Wiederholung der Konferenz wird später am Tag auf der Enovis-Website verfügbar sein.
- Enovis is hosting a conference call to discuss Q3 2024 financial results, indicating transparency with investors
- The company is providing multiple ways for investors to access the call, including a live webcast and dial-in options
- None.
Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results on Wednesday, November 6th, 2024 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on ir.enovis.com.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
+1-917-734-7450
investorrelations@enovis.com
FAQ
When will Enovis (ENOV) report its Q3 2024 earnings?
How can investors participate in Enovis's (ENOV) Q3 2024 earnings call?
Where can I find the presentation for Enovis's (ENOV) Q3 2024 earnings call?
Will there be a replay available for Enovis's (ENOV) Q3 2024 earnings call?
